We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Benchtop Instrument Automates Cell Counting

By LabMedica International staff writers
Posted on 22 Oct 2008
A benchtop instrument offers a new method of automated cell counting to replace manual cell counting using a glass hemocytometer.

Called the Countess automated cell counter, the instrument uses only 10 µl of sample, counts live and dead cells, calculates percent viability, measures average cell size, and calculates dilutions for downstream applications.

Currently, scientists use a glass slide with a grid pattern, count cells one by one, add the number of cells in each box and multiply that number by a dilution factor to calculate the final concentration of cells. More...
The Countess automates this process, completing all counts and calculations in approximately 30 seconds.

The Countess cell counter was launched by Invitrogen Corp. (Carlsbad, CA, USA), a provider of essential life science technologies for diagnostics, production, and research. "This instrument was designed with the scientists' workflows in mind, and adds to Invitrogen's already productive line of benchtop instruments, as well as the full line of reagents to support those instruments,” said August Sick, general manager and vice president of Invitrogen's Cellular Analysis Business Unit. "The Countess automates a very tedious and subjective manual process and gives accurate, repeatable results, freeing scientists to concentrate their efforts on the outcomes rather than the process.”

Related Links:
Invitrogen



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.